Clinical trials
Phase 1/2 Hodgkin Disease trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Burnasyan Federal Medical Biophysical Center | 1 |
| Chinese PLA General Hospital | 1 |
| Ciusss de L'Est de l'Île de Montréal | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
| Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 1 |
| Han weidong | 1 |
| Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale | 1 |
| New York Medical College | 1 |
| Peking University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 14 |
| Lymphoma, Non-Hodgkin | 3 |
| Myelodysplastic Syndromes | 3 |
| Anemia, Aplastic | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma | 2 |
| Lymphoma, T-Cell | 2 |
| Multiple Myeloma | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Recurrence | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.